Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-10-31

Clinical Trial Update: Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury [Phase 4]

View source ↗

Summary

Phase 4 trial investigating low-dose ketamine infusions for pain control in acute burn injury was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Pain | Phase 4 | Status: WITHDRAWN